Effectiveness of Magnetic Therapy on Pain Intensity

This study has been completed.
Sponsor:
Information provided by:
Javeriana University
ClinicalTrials.gov Identifier:
NCT00104533
First received: March 1, 2005
Last updated: March 19, 2008
Last verified: March 2005

March 1, 2005
March 19, 2008
September 2004
 
Pain intensity at rest
Same as current
Complete list of historical versions of study NCT00104533 on ClinicalTrials.gov Archive Site
  • Opioid requirements
  • Opioid side effects
Same as current
 
 
 
Effectiveness of Magnetic Therapy on Pain Intensity
Effectiveness of Magnetic Therapy on Pain Intensity

Static magnetic therapy is increasingly used to alleviate pain; however, its efficacy has not been determined yet.

The aims of this proposal are to evaluate the effect of magnetic therapy on pain intensity levels, opioid requirements, and opioid side effects.

Static magnetic therapy is increasingly used to alleviate pain; however, its efficacy has not been determined yet. The aims of this proposal are to evaluate the effect of magnetic therapy on pain intensity levels, opioid requirements, and opioid side effects.

A randomized, double blind, controlled trial is proposed. Patients from 8 years old and older subjected to a variety of surgical procedures with pain of intensity at least 5/10 will be randomized into two groups: Magnetic therapy or Placebo.

The devices will be placed around the surgical wound for 2 hours. Every ten minutes, patients will rate their pain intensity on a 0-10 numerical rating scale, and morphine will be administered until pain intensity is ≤ 4/10. Pain intensity will be the primary outcome. Opioid requirements and opioid side effects will be secondary outcomes.

To detect a difference of 1 unit (from 0 to 10) between the groups with 80% power, assuming that the baseline pain intensity is 7.9 ± 2.0, we estimated the need for 70 patients per group.

We will use an intention-to-treat analysis. To analyze the effect of the treatment on pain intensity, an analysis of repeated measures using generalized estimating equations will be used. The proportion of subjects in each group who exhibit 50% or more pain relief one hour after application of the magnetic devices and the number needed to treat will also be calculated. To analyze the effect of the treatment on opioid requirements, a difference in morphine requirements between groups two hours after placement of the magnets will be estimated. To analyze the effect of the treatment on opioid side effects, a variable that summarizes the presence of any side effect two hours after the placement of the magnets will be created, and the absolute risk difference for developing any side effect will be estimated. Ninety five percent confidence intervals will be reported.

This proposal would contribute substantially to the complementary medicine field, not only because of its scientific rigor, but also because the pain model that it evaluates strengthens the validity of the results.

Interventional
Phase 3
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Postoperative Pain
Device: Magnets
 
Cepeda MS, Carr DB, Sarquis T, Miranda N, Garcia RJ, Zarate C. Static magnetic therapy does not decrease pain or opioid requirements: a randomized double-blind trial. Anesth Analg. 2007 Feb;104(2):290-4.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
164
September 2005
 

Inclusion Criteria:

  • Hospitalized or ambulatory patients 8 years old or older subjected to surgical procedures under general anesthesia, who reported at least moderate pain.

Exclusion Criteria:

  • Subjects with surgeries longer than 3 hours
  • Multiple surgical wounds
  • Back or craniofacial surgeries, or surgeries which required cast placement, bulky dressing or the implantation of metallic devices.
  • Subjects who did not understand the pain scales employed
Both
8 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Colombia
 
NCT00104533
1753, 1203-04-16295
 
 
Javeriana University
 
Principal Investigator: M. Soledad Cepeda, MD, PhD Javeriana University School of Medicine
Javeriana University
March 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP